|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 505.78 USD | +1.81% |
|
+8.65% | +11.09% |
| 02-03 | B. Riley Adjusts Price Target on Fabrinet to $452 From $366, Maintains Neutral Rating | MT |
| 02-03 | Brace for the Earnings Flood |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.29 | 7.4 | 8.48 | 8.05 | 7.88 | |||||
Return on Total Capital | 8.6 | 10.45 | 11.7 | 10.75 | 10.89 | |||||
Return On Equity % | 14.22 | 16.94 | 18.21 | 18.43 | 17.84 | |||||
Return on Common Equity | 14.22 | 16.94 | 18.21 | 18.43 | 17.84 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 11.78 | 12.32 | 12.71 | 12.35 | 12.09 | |||||
SG&A Margin | 3.75 | 3.28 | 2.92 | 2.71 | 2.56 | |||||
EBITDA Margin % | 9.95 | 10.75 | 11.45 | 11.31 | 11.06 | |||||
EBITA Margin % | 8.1 | 9.1 | 9.84 | 9.64 | 9.53 | |||||
EBIT Margin % | 8.02 | 9.03 | 9.79 | 9.64 | 9.53 | |||||
Income From Continuing Operations Margin % | 7.89 | 8.86 | 9.37 | 10.27 | 9.72 | |||||
Net Income Margin % | 7.89 | 8.86 | 9.37 | 10.27 | 9.72 | |||||
Net Avail. For Common Margin % | 7.89 | 8.86 | 9.37 | 10.27 | 9.72 | |||||
Normalized Net Income Margin | 5 | 5.72 | 6.31 | 6.75 | 6.52 | |||||
Levered Free Cash Flow Margin | 3.35 | -1.96 | 2.28 | 8.28 | 2.32 | |||||
Unlevered Free Cash Flow Margin | 3.38 | -1.95 | 2.31 | 8.28 | 2.32 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.25 | 1.31 | 1.39 | 1.34 | 1.32 | |||||
Fixed Assets Turnover | 7.76 | 8.31 | 8.7 | 9.23 | 9.78 | |||||
Receivables Turnover (Average Receivables) | 5.93 | 5.65 | 5.37 | 5.13 | 5.06 | |||||
Inventory Turnover (Average Inventory) | 4.53 | 4.05 | 4.29 | 5.14 | 5.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.04 | 2.83 | 3.43 | 3.61 | 3 | |||||
Quick Ratio | 2.02 | 1.73 | 2.25 | 2.6 | 2.09 | |||||
Operating Cash Flow to Current Liabilities | 0.27 | 0.23 | 0.44 | 0.74 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 61.43 | 64.46 | 69.03 | 70.97 | 71.93 | |||||
Days Outstanding Inventory (Average Inventory) | 80.34 | 89.85 | 86.5 | 70.79 | 63.22 | |||||
Average Days Payable Outstanding | 61.49 | 67.54 | 67.03 | 60.63 | 62.88 | |||||
Cash Conversion Cycle (Average Days) | 80.28 | 86.77 | 88.5 | 81.13 | 72.27 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.13 | 2.49 | 0.91 | 0.29 | 0.28 | |||||
Total Debt / Total Capital | 3.97 | 2.43 | 0.91 | 0.28 | 0.28 | |||||
LT Debt/Equity | 2.81 | 1.34 | 0 | 0.21 | 0.19 | |||||
Long-Term Debt / Total Capital | 2.69 | 1.3 | 0 | 0.21 | 0.19 | |||||
Total Liabilities / Total Assets | 31.16 | 31.7 | 25.81 | 25.35 | 30.01 | |||||
EBIT / Interest Expense | 137.09 | 473.03 | 175.91 | 2.24K | - | |||||
EBITDA / Interest Expense | 172.68 | 568.26 | 207.86 | 2.66K | - | |||||
(EBITDA - Capex) / Interest Expense | 134.01 | 360.88 | 166.17 | 2.27K | - | |||||
Total Debt / EBITDA | 0.24 | 0.13 | 0.04 | 0.02 | 0.01 | |||||
Net Debt / EBITDA | -2.64 | -1.82 | -1.76 | -2.59 | -2.44 | |||||
Total Debt / (EBITDA - Capex) | 0.31 | 0.2 | 0.05 | 0.02 | 0.02 | |||||
Net Debt / (EBITDA - Capex) | -3.41 | -2.87 | -2.2 | -3.03 | -3.58 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.47 | 20.37 | 16.93 | 8.99 | 18.6 | |||||
Gross Profit, 1 Yr. Growth % | 18.95 | 25.85 | 20.7 | 5.9 | 16.07 | |||||
EBITDA, 1 Yr. Growth % | 22.96 | 29.93 | 24.24 | 8.14 | 16.04 | |||||
EBITA, 1 Yr. Growth % | 24.28 | 35.19 | 25.99 | 7.36 | 17.18 | |||||
EBIT, 1 Yr. Growth % | 24.37 | 35.48 | 26.34 | 7.36 | 17.18 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 30.72 | 35.08 | 23.72 | 19.47 | 12.27 | |||||
Net Income, 1 Yr. Growth % | 30.72 | 35.08 | 23.72 | 19.47 | 12.27 | |||||
Normalized Net Income, 1 Yr. Growth % | 22.24 | 37.76 | 28.96 | 16.59 | 14.48 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 31.23 | 35.7 | 25.56 | 20.36 | 13.21 | |||||
Accounts Receivable, 1 Yr. Growth % | 21.86 | 29.95 | 17.47 | 11.41 | 28.09 | |||||
Inventory, 1 Yr. Growth % | 36.27 | 31.98 | -6.74 | -10.85 | 25.43 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.86 | 19.58 | 5.27 | 0.19 | 23.62 | |||||
Total Assets, 1 Yr. Growth % | 16.94 | 13.58 | 7.84 | 18.13 | 21.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.23 | 12.82 | 17.28 | 18.9 | 13.55 | |||||
Common Equity, 1 Yr. Growth % | 14.17 | 12.69 | 17.15 | 18.87 | 13.52 | |||||
Cash From Operations, 1 Yr. Growth % | -21.24 | 1.71 | 71.68 | 93.68 | -20.52 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.48 | 94.5 | -31.51 | -22.54 | 154.75 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 74.1 | -174.47 | -237.23 | 298.12 | -66.83 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 67.23 | -173.26 | -240.02 | 292.23 | -66.84 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.91 | 17.38 | 18.64 | 12.89 | 13.69 | |||||
Gross Profit, 2 Yr. CAGR % | 11.14 | 22.35 | 23.25 | 13.06 | 10.87 | |||||
EBITDA, 2 Yr. CAGR % | 10.17 | 26.41 | 27.23 | 15.73 | 12.08 | |||||
EBITA, 2 Yr. CAGR % | 10.22 | 29.64 | 30.72 | 16.1 | 12.24 | |||||
EBIT, 2 Yr. CAGR % | 10.21 | 29.82 | 31.04 | 16.55 | 12.24 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 10.74 | 32.88 | 29.28 | 21.58 | 15.81 | |||||
Net Income, 2 Yr. CAGR % | 10.74 | 32.88 | 29.28 | 21.58 | 15.81 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.42 | 29.77 | 33.29 | 22.62 | 15.89 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 10.59 | 33.44 | 30.53 | 22.93 | 16.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.96 | 25.84 | 23.54 | 14.4 | 19.46 | |||||
Inventory, 2 Yr. CAGR % | 19.91 | 34.11 | 10.94 | -8.82 | 5.75 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.46 | 11.98 | 12.2 | 2.7 | 11.29 | |||||
Total Assets, 2 Yr. CAGR % | 13.46 | 15.25 | 10.68 | 12.87 | 19.59 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.81 | 13.52 | 15.03 | 18.09 | 16.2 | |||||
Common Equity, 2 Yr. CAGR % | 13.53 | 13.43 | 14.9 | 18 | 16.16 | |||||
Cash From Operations, 2 Yr. CAGR % | -10.27 | -9.19 | 32.14 | 82.35 | 24.07 | |||||
Capital Expenditures, 2 Yr. CAGR % | 50.97 | 45.48 | 15.42 | -27.16 | 40.47 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -10.33 | 10.68 | 0.67 | 132.67 | 15.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -11.74 | 7.62 | 0.85 | 133.43 | 14.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.06 | 12.61 | 17.23 | 15.33 | 14.76 | |||||
Gross Profit, 3 Yr. CAGR % | 13 | 15.84 | 21.8 | 17.17 | 14.06 | |||||
EBITDA, 3 Yr. CAGR % | 14.48 | 16.41 | 25.79 | 20.34 | 15.84 | |||||
EBITA, 3 Yr. CAGR % | 16.11 | 18 | 28.54 | 22.21 | 16.46 | |||||
EBIT, 3 Yr. CAGR % | 16.41 | 18.07 | 28.78 | 22.62 | 16.76 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.79 | 18.33 | 29.76 | 25.92 | 18.39 | |||||
Net Income, 3 Yr. CAGR % | 20.79 | 18.33 | 29.76 | 25.92 | 18.39 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.74 | 17.44 | 29.5 | 27.47 | 19.85 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 21.36 | 18.39 | 30.76 | 27.05 | 19.6 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.16 | 18.36 | 22.98 | 19.36 | 18.8 | |||||
Inventory, 3 Yr. CAGR % | 17.88 | 23.8 | 18.81 | 3.14 | 1.41 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.11 | 12.05 | 9.7 | 8.04 | 9.25 | |||||
Total Assets, 3 Yr. CAGR % | 14.1 | 13.5 | 12.73 | 13.11 | 15.54 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.81 | 13.48 | 14.76 | 16.31 | 16.56 | |||||
Common Equity, 3 Yr. CAGR % | 14.51 | 13.25 | 14.66 | 16.2 | 16.49 | |||||
Cash From Operations, 3 Yr. CAGR % | -4.93 | -5.54 | 12.29 | 50.1 | 38.26 | |||||
Capital Expenditures, 3 Yr. CAGR % | 7.93 | 68.7 | 13.18 | 1.05 | 10.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -3.59 | -17.29 | 18.56 | 58.98 | 21.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -3.83 | -18.59 | 17.14 | 58.41 | 21.8 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.98 | 9.75 | 14.03 | 12.72 | 15.8 | |||||
Gross Profit, 5 Yr. CAGR % | 13.12 | 10.2 | 16.99 | 14.72 | 17.3 | |||||
EBITDA, 5 Yr. CAGR % | 16.54 | 13.1 | 19.41 | 16.17 | 19.99 | |||||
EBITA, 5 Yr. CAGR % | 16.9 | 13.63 | 21.74 | 17.27 | 21.6 | |||||
EBIT, 5 Yr. CAGR % | 16.67 | 13.7 | 22.05 | 17.49 | 21.86 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.1 | 15.59 | 24.12 | 19.62 | 23.99 | |||||
Net Income, 5 Yr. CAGR % | 19.1 | 15.59 | 24.12 | 19.62 | 23.99 | |||||
Normalized Net Income, 5 Yr. CAGR % | 17.13 | 14.43 | 24.36 | 19.48 | 23.72 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 18.65 | 15.84 | 24.95 | 20.19 | 24.96 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.18 | 11.36 | 16.58 | 16.76 | 21.56 | |||||
Inventory, 5 Yr. CAGR % | 18.39 | 18.48 | 15.06 | 9.55 | 13.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.79 | 6.44 | 7.27 | 8.21 | 10.33 | |||||
Total Assets, 5 Yr. CAGR % | 13.56 | 12.18 | 12.72 | 13.25 | 15.43 | |||||
Tangible Book Value, 5 Yr. CAGR % | 14.88 | 13.22 | 14.9 | 15.3 | 15.33 | |||||
Common Equity, 5 Yr. CAGR % | 14.95 | 12.96 | 14.66 | 15.13 | 15.26 | |||||
Cash From Operations, 5 Yr. CAGR % | 20.3 | 11.86 | 9.09 | 22.89 | 16.86 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.93 | 5.59 | 12.65 | 20.56 | 23.39 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 109.99 | -1.11 | -3.02 | 25 | 16.99 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 117.1 | -0.93 | -3.08 | 23.96 | 15.81 |
- Stock Market
- Equities
- FN Stock
- Financials Fabrinet
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















